Rare diseases
Investigational molecules
Locations
Ul. Tarnopolska 77, 41-807 Zabrze, Poland
ClinHouse Centrum Medyczne in Zabrze, Poland specialises in clinical trials of conditions such as Dementia Alzheimer's type, Schizophrenia, Chronic obstructive pulmonary disease, Ocular myasthenia, and other specialisations. This site conducts important research.
ClinHouse Centrum Medyczne is advancing therapies for immune‑mediated conditions, with studies that assess novel agents aimed at reducing disease activity and skin involvement, while gathering long‑term safety data for patients.
The centre’s multidisciplinary team works closely with national laboratories to explore disease‑modifying potential and ensure comprehensive monitoring throughout the trials.
The neurology program concentrates on neurodegenerative disorders and primary headache conditions, testing new compounds that may lessen agitation in dementia and prevent migraine attacks, thereby improving daily functioning.
These efforts are part of a broader push to deliver disease‑modifying therapies to patients, with ClinHouse leveraging its outpatient facilities for detailed cognitive and neurological assessments.
Psychiatric research at the site focuses on severe mental illnesses, evaluating agents that could reduce negative symptoms and address treatment resistance. Ongoing studies on schizophrenia and alcohol addiction seek to enhance functional outcomes and lower relapse rates.
The program integrates psychological support with pharmacologic testing, reflecting ClinHouse’s commitment to holistic mental health care.
Clinical trials currently enrolling participants at this site.
Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
PolandOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
PolandA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
PolandStudy of VENT-03 tablets in adults with active cutaneous lupus erythematosus with or without systemic lupus erythematosus
PolandStudy of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications
PolandStudy on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia
PolandA study to test if tibulizumab works and is safe for adults with systemic sclerosis
PolandStudy on Masupirdine for Treating Agitation in Alzheimer's Dementia Patients
PolandStudy of Two Doses of EXPD-101 vs Placebo for Reducing COPD Exacerbations in Adults with Chronic Obstructive Pulmonary Disease
PolandPhase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis
PolandA Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis
PolandStudy on Sodium Oxybate for Reducing Alcohol Consumption in Patients with Alcohol Addiction
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
